Found 0 matching trials
A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease PHASE2 This is a 17-week double-blind, placebo-controlled, randomized, flexible-do...
Show More Location
Movement Disorders Center of Arizona
Learn More & Join Trial
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer PHASE2 The primary purpose of this study is to evaluate the safety, tolerability, ...
Show More Learn More & Join Trial
Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE) PHASE2 This study is designed to optimize the dosing regimen and evaluate the prel...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies PHASE1 This study is testing the safety and tolerability of BGB-21447 monotherapy ...
Show More Location
Sibley Memorial Hospital Johns Hopkins Medicine
Learn More & Join Trial
Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura PHASE3 The study was a Phase III, double-blind, placebo-controlled, randomized stu...
Show More Location
Investigator Site
Learn More & Join Trial
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors PHASE1 The purpose of this study is to find out whether the study drug, LY4101174,...
Show More Status
Active Not Recruiting
Location
AdventHealth Orlando
Learn More & Join Trial
Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis NA The aim of this trial is to conduct a 12-week randomised controlled trial c...
Show More Location
Department of Rehabilitation Sciences, The Hong Kong Polytechnic University
Learn More & Join Trial
RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis NA The implementation of a non-pharmacological multimodal intervention program...
Show More Location
Hospital Clinic de Barcelona
Learn More & Join Trial
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01) PHASE1 This is a two-part, Phase I/II, open-label, global, multicenter study asses...
Show More Location
Sarah Cannon Research Institute
Learn More & Join Trial
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors PHASE1 The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Show More Location
Tisch Cancer Institute (TCI), Icahn School of Medicine
Learn More & Join Trial